What AI says about Cx Precision Medicine

Cx Precision Medicine (CxPM) is an AI-driven diagnostics company that uses proteomics and predictive algorithms on blood samples to help detect neurodegenerative disorders, such as Alzheimer's and Parkinson's, in patients with early symptoms seen in primary care. Its NeuroFirst Memory test is a simple blood test for people aged 60 and up that helps physicians differentiate memory complaints likely due to neurodegeneration from those unlikely to be caused by Alzheimer’s or dementia, enabling earlier detection and targeted care. The company is developing additional tests, including NeuroFirst Parkinson's, and emphasizes evidence-based precision medicine and targeted intervention.